Objective: To probe into clinical application value and significance of Danhong injection for patients with acute ischemic stroke. Method: Totally 90 acute ischemic stroke patients treated in our hospital From June 2013 to June 2014 were selected. The patients were divided into study group and control group randomly. There were 45 cases in each group. The patients in control group were treated with conventional regimen

including lowering the intracranial pressure

anti-platelet aggregation and neuroprotective agents. The patients in study group were treated with Danhong injection in addition to the therapies in control group. The neurological recovery

changes of hemorheology and improvements in activities of daily living of the patients in two groups were compared and analyzed. Result: Compared with control group

the patients in study group showed significant increases in the ratio of neurological improvement at 46.67%(21/45) and total efficiency at 91.11%(41/45)

the differences were significant statistically (P<0.05). Compared with control group

after treatment

the patients in study group showed significant decreases in the plasma viscosity at (1.39±0.21) mPa·s

whole blood viscosity at high shear value at (5.91±0.12) mPa·s

whole blood viscosity at low shear value at (7.18±1.34) mPa·s

hematocrit at (40.23±4.15)%

platelet adhesion rate at (26.73±5.24)%

the differences were significant statistically (P<0.05). Compared with control group

after treatment

the patients in study group showed significant increases in BI scores at (74.61±7.82) points and FMA scores at (54.88±5.36) scores

the differences were significant statistically (P<0.05). Conclusion: Danhong injection has extremely important clinical significance in recovering nerve function

improving hemorheology and enhancing daily living for patients with acute ischemic stroke. It was worth further applying and promoting.